Should Olumiant be the JAKi of choice in rheumatoid arthritis? A review of the evidence
Free
Log In
Overview
.
This Activity for
- Resident / Fellow
- Physician
What I will learn?
"1. To review the latest Olumiant real world evidence and demonstrate the consistency of results between this and the clinical evidence.
2. To discuss why Olumiant should be used earlier in the treatment pathway and is the perfect molecule to implement a treat to target approach.
3. To agree that Olumiant should be a good contender for JAKI of choice.
About Organizer
- Virtual Medical Academy
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
| Should Olumiant be the JAKi of choice in rheumatoid arthritis? A review of the evidence Certificate | Certificate | Free |
VAT 15% Included